Large-scale drug analysis reveals potential new COVID-19 antivirals

ScienceDaily | Jul 2, 2021 at 6:02 PM
  • There are still few drug options that can be used to treat patients with the virus, to reduce symptoms and speed up recovery time.
  • In a series of seven papers, published today (2 July) in the Biochemical Journal (see https://portlandpress.com/collection/11714/Tackling-SARS-CoV-2-Biochemistry), the scientists identified 15 molecules which inhibit the growth of SARS-CoV-2 by blocking different enzymes involved in its replication.
  • The researchers developed and ran tests for around 5,000 molecules provided by the Crick’s High Throughput Screening team to see if any of these effectively blocked the functioning of any of seven SARS-CoV-2 enzymes.